Summit Therapeutics (SMMT) EBIT Margin Growth (1y) (2018 - 2022)
Powered by 
Analysis
Summit Therapeutics (SMMT) EBIT Margin Growth (1y) (2018 - 2022) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 1,135.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 7,666.00 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 1,238.00 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2,002.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -1,651.00 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 29,091.00 |
| 10 | Summit Therapeutics | 13.67 Bn | 12.98 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | -621,138.00 |
| Jun 30, 2022 | 3.62 Mn |
| Mar 31, 2022 | -4,914.00 |
| Dec 31, 2021 | -413,080.00 |
| Sep 30, 2021 | 787,105.00 |
| Jun 30, 2021 | -3.26 Mn |
| Mar 31, 2021 | -240,434.00 |
| Dec 31, 2020 | 1.26 Mn |
| Sep 30, 2020 | -517,724.00 |
| Mar 31, 2020 | -183,079.00 |
| Oct 31, 2019 | -1.23 Mn |
| Jul 31, 2019 | -1.32 Mn |
| Oct 31, 2018 | -273,415.00 |
| Jul 31, 2018 | 30,492.00 |
| Apr 30, 2018 | 23,512.00 |